Imricor Medical Systems Inc (ASX:IMR)

A$ 0.49 -0.03 (-5.77%) Market Cap: 123.67 Mil Enterprise Value: 137.83 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 18/100

Half Year 2023 Imricor Medical Systems Inc Earnings Call Transcript
Aug 23, 2023

A$0.658536 (-8.72%)

Earnings
Imricor Medical Systems Inc Ordinary Shareholders Meeting Transcript
May 11, 2023
Imricor Medical Systems Inc Extraordinary Shareholders Meeting Transcript
Mar 06, 2023
Full Year 2022 Imricor Medical Systems Inc Earnings Call Transcript
Feb 22, 2023

A$0.309899 (+1.59%)

Earnings
Imricor Medical Systems Inc Virtual Open House and Business Overview Call Transcript
Nov 18, 2022
Q3 2022 Imricor Medical Systems Inc Earnings Call Transcript
Oct 26, 2022

A$0.251793

Earnings
Half Year 2022 Imricor Medical Systems Inc Earnings Call Transcript
Aug 30, 2022

A$0.363163 (+8.70%)

Earnings
Q4 2022 Imricor Medical Systems Inc Earnings Call Transcript
Jul 27, 2022

A$0.300215

Earnings
Imricor Medical Systems Inc Annual Shareholders Meeting Transcript
May 03, 2022
Q4 2021 Imricor Medical Systems Inc Earnings Call Transcript
Feb 23, 2022

A$0.774748 (-1.23%)

Earnings
Q4 2022 Imricor Medical Systems Inc Cashflow Reports Call Transcript
Jan 26, 2022
Half Year 2021 Imricor Medical Systems Inc Earnings Call Transcript
Aug 25, 2021

A$1.19 (-1.99%)

Earnings
Imricor Medical Systems Inc Annual Shareholders Meeting Transcript
May 05, 2021
Full Year 2020 Imricor Medical Systems Inc Earnings Call Transcript
Feb 24, 2021

A$2.19 (+2.73%)

Earnings
Q4 2020 Imricor Medical Systems Inc Earnings Call Transcript
Jan 27, 2021

A$2.31 (+0.84%)

Earnings
Half Year 2020 Imricor Medical Systems Inc Earnings Call Transcript
Aug 24, 2020

A$1.57 (-4.71%)

Earnings
Q4 2020 Imricor Medical Systems Inc Cashflow Reports Call Transcript
Jul 28, 2020
Imricor Medical Systems Inc Annual Shareholders Meeting Transcript
May 12, 2020
Q4 2019 Imricor Medical Systems Inc Earnings Call Transcript
Jan 29, 2020

A$1.41 (+7.35%)

Earnings

Q4 2022 Imricor Medical Systems Inc Earnings Call Transcript

Jul 27, 2022 / 11:00PM GMT

Release Date Price: A$0.300215

Transcript

Simon Hinsley

NWR Communications Pty Ltd - Director

Good morning, and welcome to Imricor's quarterly investor webinar for the period ending 30th June 2022. On the webinar today, we have the founder and CEO, Steve Wedan, and the company's CFO, Jonathon Gus. Before I hand it over to the guys to get started and go through a brief presentation, I'll just remind you that you can ask questions through the Q&A panel at the bottom of the screen. We'll get to those post the brief presentation.

Steve, Jonathon, I'll now hand it over to you to get started. Thanks very much.

Steve Wedan;Jonathon Gut

Imricor Medical Systems, Inc. - President, CEO & Executive Chairman;Imricor Medical Systems, Inc. - CFO,

Thank you, Simon. Check that I'm off mute. Yes. Thanks, everyone, for joining us today, this morning. Imricor released its Appendix 4C for the second quarter of 2022, and we'd like to discuss these results as well as provide a general business update. So Jon will begin by presenting the quarterly cash flow results. Jon?

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.